Vol. 3 | October 2021 3 minute read

CRU banner.jpg

Clinical Science Master's Program Relaunch

classroom updated cutline.png

We are pleased to announce the relaunch of UTSW’s Master of Science in Clinical Science and related certificate programs. 

 

Designed for those who aim to accelerate their clinical and translational research careers, the program includes courses on research training and financial planning, leadership, and career development. Graduates will have the knowledge to plan and conduct their own clinical and translational research programs and apply for grant funding. 

 

Core Coursework 

  • Biostatistics 
  • Introduction to the Design and Analysis of Clinical and Translational Research 
  • Grant Writing and Funding Strategies
  • Responsible Conduct of Research
  • Essentials of Management and Leadership 

 

Individuals who are interested in pursuing coursework for the spring 2022 semester can enroll in mid-November. On Dec. 1, the application portal will open to start the process to enroll for the 2022 Master's degree program. 

 

For enrollment information and general questions, contact the program’s Education Coordinator, Trina Corley, or program co-directors Dr. Heidi Jacobe, Professor of Dermatology, and Dr. Scott Smith, Professor and Chair of the Department of Applied Clinical Research. 

Decrease in IRB Review Turnaround Time

IRB graph v4.jpg

Numerous organizational, procedural, technical, and regulatory changes over the past six years have resulted in decreased turnaround times for IRB reviews. There was a temporary increase in turnaround for Exempt and Expedited studies in FY19 as a result of changes to federal regulations (Revised Common Rule). The graph shows two lines for Full Board review: “Decision” (in orange) represents the time for studies to be initially reviewed by the convened IRB, whereas “Full Approval” (in light blue) represents the time for final approval to be issued after IRB stipulations have been satisfied. 

Processing Data Use Agreements (DUA) for Research

GettyImages-1179640294-600x410.jpg

Data use agreements (DUA) are commonplace in clinical research. As a rule, a DUA may be required by UTSW whenever data will be shared with outside entities.  

 

Data from clinical research in general should not be shared with outside entities without an evaluation by the UT Southwestern Human Research Protection Program (HRPP) of the need for a DUA. The HRPP will determine if a DUA is needed when the study (or modification to the study) is submitted online to the Institutional Review Board (eIRB) for review.  

 

DUAs are neither created nor signed by the investigators but rather signed by the UTSW official with appropriate delegated signature authority. The researcher, however, should review and understand the terms of a DUA as they need to conform to those terms.  

 

We are working on creating a simplified, transparent, and efficient DUA process. In the meantime, we will abide by these general guidelines: 

 

A standard DUA is required when: 

  • Data transfer takes place between the provider and the recipient in the absence of a signed HIPAA authorization or HIPAA waiver that describes the data sharing, or 
  • Data is being shared with a commercial entity and has intellectual property (IP) potential.  

 

A custom DUA may be required when any of the following are true:  

  • Biospecimens are also shared (this requires Material Transfer Agreement language).  
  • The recipient of the data will not accept the terms of the standard DUA.
  • Research is more complicated (e.g., multisite consortium).  

 

A business associate agreement (BAA) is required when: 

  • Protected health information that is individually identifiable will be shared/transferred to a vendor who will provide a service for UTSW. 

 

A DUA is not required:  

  • When a study is funded by an outside entity such as a private-for-profit, private not-for-profit, or foundation, and the transfer of data from one entity to another is addressed in the context of a larger agreement between the parties, such as a sub-award agreement or a clinical trial agreement.  
  • If the patient signs a HIPAA authorization or the IRB/HRPP waives the requirement for a HIPAA authorization.  

 

Note: The DUA processes outlined above is specific to UTSW analyses and may not apply to data acquired through the Parkland Health & Hospital System, Children's Health, Scottish Rite for Children, and Texas Health Resources. 

 

For more information, contact Rhonda Oilepo, M.S., CIP, CHRC, CHPC, Assistant Vice President, Human Research Administration.  

 

Ware Clinical Impact Fund Awardees

Dr Salman Bhai_08112020_NEURO_5941 resize 2.jpg

2021 Awardee:

Salman Bhai, M.D.

Neurology


Research Topic:

"MyoCADET: Cardiovascular Determinants of Exercise in Tolerance in Myositis"

Dr-Parag-Joshi_09122018_RAD-ONC_3237 resize.jpg

2021 Awardee:

Parag Joshi, M.D.

Internal Medicine


Research Topic:

"CT Defined LVH Determination and Role in Risk Stratification"

The 2021 Ware Clinical Impact Fund has been awarded to Dr. Salman Bhai, Director of the Neuromuscular Center at the Institute of Exercise and Environmental Medicine and Assistant Professor of Neurology, and Dr. Parag Joshi, Associate Professor in the Department of Internal Medicine’s Division of Cardiology. Each will receive $50,000 for their clinical research.  


The award, established in 2019 by Amy and Leslie Ware, supports clinicians interested in taking time away from the clinic to pursue research projects relating to the heart or brain. Practicing clinicians who are faculty members in any of the 21 clinical departments are eligible to apply. 

Clinical and Translational Research Forum

This interactive forum provides an opportunity for trainees to meet with established investigators in clinical and translational research to share their ideas and experiences. 

 

Thursday, Nov. 4 at noon

Dr. Eric Peterson, Vice Provost and Senior Associate Dean for Clinical Research  

“The Career Path: The Roles of Serendipity and Skill” 

 

Thursday, Dec. 9 at noon

Dr. Lina Chalak, Professor of Pediatrics and Psychiatry

“A Scholar’s Journey in Neonatal Asphyxia: From Translational Studies to Clinical Trials to

Program Development” 

 

Join via Zoom; meeting ID 918 5345 2714, passcode 361531

 

Beginning Thursday, Jan. 20, the forum will be weekly, from noon to 1 p.m.  

Connect with Colleagues


Use our social media channels to stay in the know about happenings across campus. Submit feedback and topic suggestions for the newsletter through our RedCap form.

Facebook  LinkedIn  Twitter